FSU scientist Hengli Tang has spent years studying Hepatitis C and researching how to stop its spread.
"We're really not working on a vaccine, we're working on drug candidates to treat the virus," says Tang, who explains that Hepatitis C is a blood born pathogen which causes inflammation of the liver.
He and a team of researchers have discovered the molecular mechanism that inhibits the virus' replication.
"Hepatitis C is such a widespread problem in the United States," says post-doctoral associate Jason Robotham.
"We are looking to improve the measures for identifying the candidate drugs that can stop the viral infection. That's our long-term goal," adds Tang, who hopes his research helps combat a virus which has already affected close to four million Americans.
The Centers for Disease Control reports 2.7 million Americans are chronically affected by Hepatitis C.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.